BiykemBozkurt
@biykemb
Editor-in-Chief JACC:HF, Senior Dean of Faculty, Baylor College of Medicine, Cain Chair, Prof of Med & Director of Winters Ctr for Heart Failure, Mother of 3
ID: 1025948047707127809
05-08-2018 03:34:10
3,3K Tweet
5,5K Followers
1,1K Following
GWTG-HF data shows ~80% of patients with newly diagnosed #HFrEF are eligible for #quadtherapy yet 1/6 receive it. If prescribed, rapid initiation of #GDMT at the time of HF diagnosis yields large absolute mortality reductions. bit.ly/3Mn0oq7 Gregg Fonarow MD Steve Greene #JACCHF
🔥❤️🔥 #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV ☠️ & Total #HHF 🏥 A 2nd pillar for #HFmrEF & #HFpEF has just been built 🏛️ #HFUA EJHF Editor-in-Chief NEJM Gregg Fonarow MD James Januzzi Jr MD Andrew J Sauer MD BiykemBozkurt Michele Emdin Ritu Thamman MD Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 bit.ly/3TdO13r
Mineralocorticoid receptor antagonists (MRAs) remain underutilized for heart failure. New data on nonsteroidal MRAs is promising for improved heart failure treatment. bit.ly/4e07BYF #JACCHF #ESCCongress #HeartFailure Andrew J Sauer MD
What a moment! The Lancet Editor richard horton and #JACC Editor Harlan Krumholz came together to celebrate the new partnership between the Journals. A rare opportunity for the two platforms to come together to improve CV care!
Beautiful venue for JACC Journals reception at #ESCCongress yesterday! Great opportunity to meet the leaders in #CVcare, Inspiring convos and thoughtful discussion. #Selfies of #ESCCongress
Happening now in Belgrade: dive into the latest breakthroughs in #hypertension drug therapies! 💊 Led by the expert chairs BiykemBozkurt and #AnthonyRodgers—! #ESCCongress
Exploring #AldosteroneSynthaseInhibition for #hypertension with Dr. Dr. Deepak L. Bhatt: 📍 #Baxdrostat: A highly selective #ASI 📍 some studies: #BrigHTN and #HALO for uncontrolled #HTN 📍 #Aldosterone plays a vital role in poorly controlled or resistant #HTN 📍 Potential ⬆️
From ACC Vice President Christopher Kramer MD at #ESCCongress: CMR in #myocarditis: when should a genetic #cardiomyopathy be suspected? ⬇️ Clues: 🔍 Family history 🔍 Recurrent myocarditis 🔍 Septal or ring-like LGE 🔍 LV dysfunction bit.ly/3AAwQ5o #JACC #JACCHF #ACCBOT
New JACC Journals #JACCHF 🫀❤️🩹 ‼️Rapid uptitration of #GDMT ▪️⬇️ #HF-related morbidity & mortality 🌟Regardless of underlying HF risk profile DOI: 10.1016/j.jchf.2024.04.017
Recognition of preshock or early CS states is important to facilitate early identification, to guide appropriate triage and to enable prompt interventions aimed at delaying or preventing the onset of overt CS. bit.ly/3zeRsQn #JACCHF Sid M. Patel TIMI Study Group
New in #JACCHF: 🔥 Obesity & Weight Loss Strategies for Patients with Heart Failure Nice review of this important target in the management of #HF JACC Journals JACC HF: jacc.org/doi/10.1016/j.…
Now in JACC Journals #JACCHF, analysis ▶️ DAPA-HF+DELIVER ✅ Pts w/ recent HFH had highest clinical risk + greatest benefit post randomization for risk reduction of worsening HF + CV 💀 Pre-discharge implementation of #GDMT more important than ever tinyurl.com/4dr6y89p
🔥🔥 ☠️ for phenotypes along preshock -> CS continuum 👉 jacc.org/doi/full/10.10… JACC Journals #JACCHF Critical Care Cardiology Trials Network 🎯 Hypoperfusion +/- hypotension -> ⬆️☠️ 🎯 normotensive CS -> distinct CS phenotype 🎯 Identify pre-& early shock to improve #CardiogenicShock outcomes
Critical Care Cardiology Trials Network registry data 2017 to 2023 4 groups: No end organ dysfunction- -Isolated ⬇️ CO; -HF with isolated ⬇️ BP W End organ dysfunction: -normotensive CS (MAP > 60, SBP > 90) -classic #SCAI stage C CS 2498 CICU admissions ~ above 4 definitions Stage D or E excluded